Rob Dillard

DocwireNews

For patients with B-cell chronic lymphocytic leukemia (CLL), an ELISA method proves effective and feasible at identifying patients who are candidates for personalized therapeutic strategies, according to a study presented at the SOHO 2024 Annual Meeting.Researchers analyzed 20 patients admitted to the hospital with symptoms and clinical features of CLL, such as cough, night sweating, and retrosternal pain. Subsequently, clinical examination and ultrasound revealed adenopathy and/or splenomegaly.The findings showed that p53 protein concentrations were 20, 15, 18, 40, 10, 12, 14, 60, 30, 10, 13, 15, 10, and 12 &micro;g/dL in men and 140, 30, 13, 20, 25, and 10 &micro;g/dL in women, respectively. The researchers noted that the probability index was P=.034. Moreover, the researchers established a reference interval between 10 and 40 &micro;g/dL, (mean value for men=19.9 &micro;g/dL; women=39.6 &micro;g/dL). The investigators noted that the pathological values reflecting the concentration of mutant p53 protein emphasizes the frequency of CLL with mutant p53 protein being higher in men than women, in a ratio of 2:1, in accordance with data from the specialized literature.&ldquo;In the context of B-cell CLL, a simple and inexpensive ELISA method proves useful for identifying patients to be considered as candidates for personalized therapeutic strategies in the presence of p53 protein isoforms,&rdquo; the researchers concluded.ReferenceUdristioiu A, Cojocaru M, Nica-Badea D. Identification and Diagnosis of Possible Mutations in Human p53 Lymphocytes. Abstract #CLL-042. Presented at the Society of Hematologic Oncology Meeting 2024; September 4-7, 2024; Houston, Texas.&nbsp;&nbsp;

BMI Modifies the Relationship Between Glycemic Status and Asthma Severity in Children

Asthma

Jordana Jampel

Cutaneous Melanoma: Sun Protection Behaviors and UV Exposure in Canada

Melanoma

Leah Lawrence

Significant Cardiac Benefit Seen With Ifetroban in Patients With Duchenne Muscular Dystrophy

Neurology

Latest News

Identification and Diagnosis of Possible Mutations in Human p53 Lymphocytes in Patients With B-cell CLL

SOHO 2024: Focus on CLL

For patients with B-cell CLL, a simple method is effective at identifying patients eligible for personalized therapies. 

Identification and Diagnosis of Possible Mutations in Human p53 Lymphocytes in Patients With B-cell 

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe